BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Z, Zhong L, He K, Qiu C, Li Z, Zhao L, Gong J. Cholesterol attenuated the progression of DEN-induced hepatocellular carcinoma via inhibiting SCAP mediated fatty acid de novo synthesis. Biochem Biophys Res Commun 2019;509:855-61. [PMID: 30638930 DOI: 10.1016/j.bbrc.2018.12.181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wei RL, Fan GH, Zhang CZ, Chen KC, Zhang WH, Li CB, Dong SY, Chen JL, Ling SB, Zheng SS, Xu X. Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00123-0. [PMID: 35613994 DOI: 10.1016/j.hbpd.2022.05.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li T, Yang G, Hao Q, Zhang X, Zhang X. Daphnetin Ameliorates the Expansion of Chemically Induced Hepatocellular Carcinoma via Reduction of Inflammation and Oxidative Stress. J Oleo Sci 2022;71:575-85. [DOI: 10.5650/jos.ess21415] [Reference Citation Analysis]
3 Guo C, Guo X, Rong Y, Guo Y, Zhang L. Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma. Biomed Res Int 2021;2021:9458328. [PMID: 34651050 DOI: 10.1155/2021/9458328] [Reference Citation Analysis]
4 Ribas V, de la Rosa LC, Robles D, Núñez S, Segalés P, Insausti-Urkia N, Solsona-Vilarrasa E, Fernández-Checa JC, García-Ruiz C. Dietary and Genetic Cholesterol Loading Rather Than Steatosis Promotes Liver Tumorigenesis and NASH-Driven HCC. Cancers (Basel) 2021;13:4091. [PMID: 34439245 DOI: 10.3390/cancers13164091] [Reference Citation Analysis]
5 Conde de la Rosa L, Garcia-Ruiz C, Vallejo C, Baulies A, Nuñez S, Monte MJ, Marin JJG, Baila-Rueda L, Cenarro A, Civeira F, Fuster J, Garcia-Valdecasas JC, Ferrer J, Karin M, Ribas V, Fernandez-Checa JC. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway. J Hepatol 2021;74:1429-41. [PMID: 33515644 DOI: 10.1016/j.jhep.2021.01.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chan LK, Ho DW, Kam CS, Chiu EY, Lo IL, Yau DT, Cheung ET, Tang CN, Tang VW, Lee TK, Wong CC, Chok KS, Chan AC, Cheung TT, Wong CM, Ng IO. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma. J Hepatol 2021;74:360-71. [PMID: 32918955 DOI: 10.1016/j.jhep.2020.08.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Garcia-Ruiz C, Conde de la Rosa L, Ribas V, Fernandez-Checa JC. MITOCHONDRIAL CHOLESTEROL AND CANCER. Semin Cancer Biol 2021;73:76-85. [PMID: 32805396 DOI: 10.1016/j.semcancer.2020.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]